Recently, two missense mutations of the HIPK2 gene have been identified in acute myeloid leukaemia (AML) and in myelodysplastic syndrome (MDS), a pre-leukaemia syndrome [6]. This evidence concerns the gene HIPK2 and acute myeloid leukemia.